Massive transfusion in obstetric hemorrhage: What are the risk factors and can they be predicted?

Basit Öğe Kaydı
dc.contributor.authorAktemur, Gizem
dc.contributor.authorÇalışkan, Şeyda
dc.contributor.authorKarabay, Gülşan
dc.contributor.authorYurtçu, Engin
dc.contributor.authorÖzbay, Koray
dc.contributor.authorAtalay, Nihan Erdoğan
dc.contributor.authorSaraç, Ömer Doğukan
dc.date.accessioned2025-03-24T19:47:13Z
dc.date.available2025-03-24T19:47:13Z
dc.date.issued2025
dc.departmentDüzce Üniversitesi
dc.description.abstractObjectives: This study aims to identify the risk factors associated with massive transfusion in obstetric hemorrhage and evaluate their predictive value to facilitate early intervention and improve maternal outcomes. Methods: A retrospective cohort study was conducted on 1305 women who received blood transfusions for obstetric hemorrhage at Etlik City Hospital between October 2022 and December 2024. Patients were categorized into two groups: those who required massive transfusion (?10 units of blood products) and those who received at least one unit of transfusion. Demographic, clinical, obstetric, and hematological parameters were analyzed. Statistical comparisons were performed using chi-square, Fisher's exact, Mann-Whitney U, and independent sample t-tests. Results: A history of recurrent miscarriage, two or more previous cesarean sections, congenital uterine abnormalities, and uterine rupture were significantly associated with massive transfusion (P<0.01). Severe anemia (Hb<9 g/dL) and thrombocytopenia were also identified as critical hematological predictors (P<0.001). Socioeconomic factors, including low educational attainment and unemployment, were significantly correlated with the need for massive transfusion (P<0.001). Obstetric complications such as postpartum atony (P<0.001) and premature rupture of membranes (P=0.04) also contributed to increased transfusion risk. Conclusions: Identifying key risk factors for massive transfusion can aid in early recognition and timely intervention for obstetric hemorrhage. Integrating these predictors into clinical protocols may enhance maternal care by improving preparedness and reducing maternal morbidity and mortality.
dc.identifier.doi10.18621/eurj.1634732
dc.identifier.endpage435
dc.identifier.issn2149-3189
dc.identifier.issue2
dc.identifier.startpage427
dc.identifier.urihttps://doi.org/10.18621/eurj.1634732
dc.identifier.urihttps://hdl.handle.net/20.500.12684/18576
dc.identifier.volume11
dc.language.isoen
dc.publisherPrusa Medical Publishing
dc.relation.ispartofThe European Research Journal
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_DergiPark_20250324
dc.subjectObstetric hemorrhage|massive transfusion|risk factors|postpartum atony|anemia|cesarean section|maternal morbidity.
dc.titleMassive transfusion in obstetric hemorrhage: What are the risk factors and can they be predicted?
dc.typeArticle

Dosyalar

Koleksiyon

Öksüz Yayınlar Koleksiyonu